http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2004207-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ec971282fb88eaeb30dfafae62f25c15 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_db4025c3694ea8cb67b6e1f74d3fc91c |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-708 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-70 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-70 |
| filingDate | 2007-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6c2ca0855f98c6b001e600dc791647fd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2d30bd33c824ba30d3d58b7c98c7edc7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_232a859601edfa66db83b0cfd806746e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_26cf87bd1f7d0b0dc2657d54c0d37f72 |
| publicationDate | 2008-12-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-2004207-A1 |
| titleOfInvention | Active substance fractions for formulations for the therapy and prophylaxis of inflammatory diseases |
| abstract | The invention relates to antioxidant substance fractions produced from Rheum species for formulations for the therapy and prophylaxis of inflammatory or autoimmune diseases and/or diseases with disturbed keratinocyte proliferation. The active substance fractions are obtained by extraction of the dried and ground root samples with methanol, the aqueous phase so produced is liberated from lipophilic accompanying substances while completely removing the methanol, the purified aqueous phase is extracted by shaking with ethyl acetate, the resulting aqueous phase and the combined ethyl acetate phase are processed separately, separated by column chromatography to give a limited number of active substance fractions and the active substance fractions from the aqueous phase and from the ethyl acetate phase having the same spectrum of constituents are each combined. |
| priorityDate | 2006-04-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 363.